Idhifa: Now Approved/Available Website




Brand: Idhifa (enasidenib), Tablets
Parent Company: Celgene
Drug Type: Boxed Warning
Drug Category: Oncology
Campaign: now-approved, Now Available
Targeting: HCPs, Patients
Patient Website: http://www.idhifa.com/
HCP Website: http://www.idhifapro.com/